[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.150.57. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

The Treatment of Substance Use Disorders and Addiction During COVID-19Emergency Treatment of Pain, Buprenorphine Prescribing During Pandemic, COVID-19 Impact on Alcohol Use, Access to Care, Treatment Models (May 2020)

Learning Objectives
1. Describe outcomes that lead to improvement in response perspectives on navigating challenges that arise during novel care delivery
2. Explain methods to navigate challenges that arise utilizing telehealth and phone support
3. Identify related changes in monitoring for patients treated for opioid use disorder and in novel settings
4. Recognize medication availability for patients treated for opioid use disorder and in novel settings
1 Credit CME

Cases: 1. A 58-year-old M with opioid use disorder treated with 8/2 mg buprenorphine/naloxone two films/day is diagnosed with nephrolithiasis after an emergency trip to the hospital.; 2. A 60-year-old F who, under normal circumstances, receives 2 weeks RX but since the COVID-19 pandemic has received 30 days RX to minimize travel and contact with the pharmacy. She calls 8 days early reporting she is "out."; 3. A 22-year-old F with alcohol use disorder, who has increased her drinking since the COVID-19 pandemic, reaches out for help.

Sign in to take quiz and track your certificates

To help improve the quality of its educational content and meet applicable education accreditation requirements, the content provider will receive record of your participation and responses to this activity.

American Society of Addiction Medicine (ASAM) Education supports clinicians by increasing access and improving care in all aspects of addition care: prevention, treatment, remission, and recovery. Learn more

Video Information:

AMA Credit Designation Statement: The American Society of Addiction Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Accreditation Statement: The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

National Board for Certified Counselors ACEP: The American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. The American Society of Addiction Medicine is solely responsible for all aspects of the programs.

NAADAC, the Association for Addiction Professionals: This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP):This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs): Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification

American Board of Preventive Medicine (ABPM): The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 10 LLSA credit towards ABPM MOC Part II requirements.

American Board of Anesthesiology (ABA): This activity contributes to the CME component of the American Board of Anesthesiology's redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

American Board of Pediatrics (ABP): Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 10 MOC points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Internal Medicine (ABIM): Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Surgery (ABS): Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery's Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

American Board of Psychiatry and Neurology (ABPN): Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology's (ABPN) CME requirement for Maintenance of Certification program.

American Board of Addiction Medicine (ABAM): Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

CME Reviewer and Disclosure Information

ASAM CME Committee Reviewer

Edwin A. Salsitz, MD, DFASAM

Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

ACCME's Policy For Disclosures During The COVID-19 Pandemic

Per ACCME's simplified process for COVID-19, the requirement of disclosure of relevant financial relationships and resolution of personal conflicts of interest has been removed. Currently, there are no FDA-approved vaccines or treatments for COVID-19. Hence, there is no possibility of a relevant financial relationship that would create a conflict of interest.

Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
Close